Simple conditioning with monospecific CD4+CD25+ regulatory T cells for bone marrow engraftment and tolerance to multiple gene products
Open Access
- 15 September 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 108 (6) , 1841-1848
Abstract
A major impediment to gene replacement therapy is immune elimination of genetically modified cells. In principle, this can be dealt with by inducing a strong, specific, and enduring tolerance through engraftment of transgene-modified autologous bone marrow (BM). Because usual myeloablation and/or immunosuppression are risk factors in most pathologies, we assessed the potential of monospecific CD4+CD25+ regulatory T cells (Tregs) to engraft minor-mismatched BM without preconditioning. We found that as few as 5 × 104 Tregs directed to the male DBY protein promote the engraftment of foreign male BM into sex-mismatched female hosts, establishing sustained chimerism in all hematopoeitic compartments. We achieved concomitantly strong tolerance to all foreign antigens expressed in the BM, likely occurring through induction of anergy and/or deletion of antidonor T cells. Chimerism was obtained in thymectomized mice too, underlining the major role of peripheral tolerance mechanisms in our system. This allowed us to engraft gene-modified tissues while preserving full immunocompetence to third-party antigens. Our results demonstrate that very few donor-specific Tregs are effective as the sole conditioning to induce mixed molecular chimerism and long-term tolerance to multiple foreign antigens.Keywords
This publication has 51 references indexed in Scilit:
- Antigen-specific regulatory T cells—Ex vivo expansion and therapeutic potentialSeminars in Immunology, 2006
- CD25+ CD4+ T Cells, Expanded with Dendritic Cells Presenting a Single Autoantigenic Peptide, Suppress Autoimmune DiabetesJournal of Experimental Medicine, 2004
- In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune DiabetesJournal of Experimental Medicine, 2004
- CD4+CD25+ regulatory T cells inhibit immune-mediated transgene rejectionBlood, 2003
- Dangerous liaisons: the role of “danger” signals in the immune response to gene therapyBlood, 2002
- CD4+CD25+ Immunoregulatory T CellsJournal of Experimental Medicine, 2002
- Origin of regulatory T cells with known specificity for antigenNature Immunology, 2002
- Muscle-Directed Gene Transfer and Transient Immune Suppression Result in Sustained Partial Correction of Canine Hemophilia B Caused by a Null MutationMolecular Therapy, 2001
- A COMPARISON OF THE SURVIVAL OF H-Y INCOMPATIBLE EAR, TAIL, AND BODY SKIN GRAFTSTransplantation, 1976
- DIFFERENCES IN THE REJECTION OF TRUNK SKIN AND TAIL SKIN ALLOGRAFTS INVOLVING WEAK HISTOCOMPATIBILITY LOCITransplantation, 1975